Andrew Lane
4Patents
1h-index
11Co-inventors
37Inventor score
Filing activity: Jun 2, 2016 → Sep 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11273442B1 | Programmable nuclease compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 19 | Active |
| US11279926B2 | Methods and compositions for generating CRISPR/Cas guide RNAs | Chemistry; Metallurgy | 0 | Active |
| US11674950B2 | Methods determining and treating cellular resistance to ADP-rtbosylating toxin | Physics | 0 | Active |
| US11761029B2 | Programmable nuclease compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.